NCT05150691 2026-01-28A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid TumorsDualityBio Inc.Phase 1/2 Recruiting796 enrolled
NCT03878524 2024-03-04Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME TrialOHSU Knight Cancer InstitutePhase 1 Terminated2 enrolled
NCT01835236 2021-03-30Trastuzumab & Pertuzumab Followed by T-DM1 in MBCSwiss Cancer InstitutePhase 2 Completed208 enrolled
NCT02139358 2021-02-04Phase I/IIa Trial of Gemcitabine Plus Trastuzumab and Pertuzumab in Previously Treated Metastatic HER2+ Breast CancerH. Lee Moffitt Cancer Center and Research InstitutePhase 1/2 Completed15 enrolled 12 charts
NCT01048099 2016-01-29Use of PRO Onc Assay to Assess HER2 in Patients With Metastatic Breast CancerSCRI Development Innovations, LLCPhase NA Completed283 enrolled 8 charts